Novartis CEO Joseph Jimenez to Retire in 2018

Wednesday, September 6 2017 | 00 h 00 min | News, Press Release

Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, has informed the Board of Directors of his desire to step down as CEO in 2018, after eight years in the position. The Board of Directors has appointed Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as CEO of Novartis, effective February 1, 2018. Dr. Narasimhan is a member of the Executive Committee and joined Novartis in 2005.

Dr. Narasimhan has held numerous leadership positions across Novartis in commercial, drug development and strategy roles. Prior to his current role he served as Head of Development for Novartis Pharmaceuticals.

Dr. Narasimhan said, “I would like to congratulate Joe and express my gratitude to Joe, Joerg, and the Board of Directors. I feel honored and humbled to be asked to lead Novartis. We will continue our legacy of bringing leading innovation to patients around the world.”

Featured Posts

Optik VOILA January-February 2026 Marchon LO2187_714

Modern Elegance in a Sleek Teardrop Silhouette

Longchamp’s LO2187 reinterprets the Roseau concept with a lightweight metal teardrop silhouette, bamboo-inspired bridge detailing, and refined comfort for everyday wear.

Learn More

Landmark Myopia Control Trial Receives Top Recognition

A landmark six-year clinical trial on dual-focus contact lenses confirms long-term effectiveness in slowing childhood myopia progression.

Read more

Next Gen OD Future Focus event Cross-border Guidance 2026

Future Focus Webinar Addresses Cross-Border Pathways for Canadian Optometry Students

The Future Focus Cross-Border webinar provided Canadian optometry students with guidance on immigration, licensing and returning to practice in Canada.

Read more

Seneca College Trade Show: Still Going Strong

The Seneca College Trade Show continues to connect opticianry students with key suppliers, associations and professionals across the optical industry.

Read more

Vision Council Report: Eyecare Providers See Revenue Gains Despite Economic Pressures

The Vision Council’s Provider inSights report finds eyecare providers saw revenue gains and improved patient retention in late 2025 despite ongoing economic pressures.

Read more

Optik VOILA January-February 2026 Marchon LO2187_714

Modern Elegance in a Sleek Teardrop Silhouette

Longchamp’s LO2187 reinterprets the Roseau concept with a lightweight metal teardrop silhouette, bamboo-inspired bridge detailing, and refined comfort for everyday wear.

Learn More

Landmark Myopia Control Trial Receives Top Recognition

A landmark six-year clinical trial on dual-focus contact lenses confirms long-term effectiveness in slowing childhood myopia progression.

Read More

Next Gen OD Future Focus event Cross-border Guidance 2026

Future Focus Webinar Addresses Cross-Border Pathways for Canadian Optometry Students

The Future Focus Cross-Border webinar provided Canadian optometry students with guidance on immigration, licensing and returning to practice in Canada.

Read More

Seneca College Trade Show: Still Going Strong

The Seneca College Trade Show continues to connect opticianry students with key suppliers, associations and professionals across the optical industry.

Read More

Vision Council Report: Eyecare Providers See Revenue Gains Despite Economic Pressures

The Vision Council’s Provider inSights report finds eyecare providers saw revenue gains and improved patient retention in late 2025 despite ongoing economic pressures.

Read More

Optik VOILA January-February 2026 Marchon LO2187_714

Modern Elegance in a Sleek Teardrop Silhouette

Longchamp’s LO2187 reinterprets the Roseau concept with a lightweight metal teardrop silhouette, bamboo-inspired bridge detailing, and refined comfort for everyday wear.

Learn More

Landmark Myopia Control Trial Receives Top Recognition

A landmark six-year clinical trial on dual-focus contact lenses confirms long-term effectiveness in slowing childhood myopia progression.

Read more

Next Gen OD Future Focus event Cross-border Guidance 2026

Future Focus Webinar Addresses Cross-Border Pathways for Canadian Optometry Students

The Future Focus Cross-Border webinar provided Canadian optometry students with guidance on immigration, licensing and returning to practice in Canada.

Read more

Seneca College Trade Show: Still Going Strong

The Seneca College Trade Show continues to connect opticianry students with key suppliers, associations and professionals across the optical industry.

Read more

Vision Council Report: Eyecare Providers See Revenue Gains Despite Economic Pressures

The Vision Council’s Provider inSights report finds eyecare providers saw revenue gains and improved patient retention in late 2025 despite ongoing economic pressures.

Read more

Optik VOILA January-February 2026 Marchon LO2187_714

Modern Elegance in a Sleek Teardrop Silhouette

Longchamp’s LO2187 reinterprets the Roseau concept with a lightweight metal teardrop silhouette, bamboo-inspired bridge detailing, and refined comfort for everyday wear.

Learn More

Landmark Myopia Control Trial Receives Top Recognition

A landmark six-year clinical trial on dual-focus contact lenses confirms long-term effectiveness in slowing childhood myopia progression.

Read more

Next Gen OD Future Focus event Cross-border Guidance 2026

Future Focus Webinar Addresses Cross-Border Pathways for Canadian Optometry Students

The Future Focus Cross-Border webinar provided Canadian optometry students with guidance on immigration, licensing and returning to practice in Canada.

Read more

Seneca College Trade Show: Still Going Strong

The Seneca College Trade Show continues to connect opticianry students with key suppliers, associations and professionals across the optical industry.

Read more

Vision Council Report: Eyecare Providers See Revenue Gains Despite Economic Pressures

The Vision Council’s Provider inSights report finds eyecare providers saw revenue gains and improved patient retention in late 2025 despite ongoing economic pressures.

Read more